Ken H. Young, MD, PhD, shares some highlights of this review series. The success of antibodies in fighting infection is clear, but directing this power against cancer cells has been a challenge. For cancer, antibodies are usually made externally and injected into patients, where they act against

中文翻译：

---

治疗性抗体综述系列简介

医学博士 Ken H. Young 分享了本系列评论的一些亮点。抗体在对抗感染方面的成功是显而易见的，但将这种力量直接对抗癌细胞一直是一个挑战。对于癌症，抗体通常在外部制造并注射到患者体内，在那里它们对